VERTEX PHARMACEUTICALS INCORPORATED
Proposal 1.
Election of ALAN GARBER as director
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1.
Election of MARGARET G. MCGLYNN as director
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1.
Election of WILLIAM D. YOUNG as director
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 2.
AMENDMENTS TO OUR CHARTER AND BY-LAWS TO PROVIDE FOR THE DECLASSIFICATION OF OUR BOARD OF DIRECTORS.
Caisse vote:
For
Applicable policy or principle:
PR_05_08
Proposal 3.
AMENDMENT AND RESTATEMENT OF OUR 2013 STOCK AND OPTION PLAN, TO AMONG OTHER THINGS, INCREASE THE NUMBER OF SHARES AVAILABLE UNDER THE PLAN BY 6.75 MILLION SHARES.
Caisse vote:
Against
Applicable policy or principle:
PR_07_02
Proposal 4.
RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017.
Caisse vote:
For
Applicable policy or principle:
PR_06
Proposal 5.
ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.
Caisse vote:
Against
Applicable policy or principle:
PR_07_06
Proposal 6.
ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION PROGRAM.
Caisse vote:
For
Applicable policy or principle:
PR_07_06
Proposal 7.
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE TAKE STEPS NECESSARY TO ELIMINATE SUPERMAJORITY PROVISIONS FROM OUR CHARTER AND BY-LAWS.
Caisse vote:
For
Applicable policy or principle:
PR_11_03
Proposal 8.
SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE PREPARE A REPORT ON OUR POLICIES AND ACTIVITIES WITH RESPECT TO LOBBYING.
Caisse vote:
For
Applicable policy or principle:
PR_13_03